Linkedin X-twitter Youtube
Launch Digital Edition

Webinars and Sponsored Roundtables — Register Now

Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.

Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy,  CEO of mTuitive.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice

Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Subspecialties

Interactive Product Guides

Marketplace

Quality controls, critical raw materials, 10/16

October 2016—Bio-Rad Laboratories launched Amplichek II quality control, which was issued a de novo clearance from the FDA. Amplichek II is the first in a series of infectious disease controls that the company is introducing to the molecular diagnostic testing market. It is an independent, multianalyte quality control that monitors the performance of in vitro laboratory nucleic acid testing procedures for the qualitative detection of health care–associated infections.

Lateral flow immunoassay reader, distribution agreement, 10/16

October 2016—Abingdon Health announced the CE marking and FDA registration of its immunoassay reader, the ADxLR5, as a class I medical device. The ADxLR5 lateral flow device reader is designed to offer the most up-to-date features required for rapid testing, including a touchscreen user interface, barcode sample identification, stored calibration curve processing, and Wi-Fi or wired connectivity.

Next-gen diagnostics systems, 10/16

October 2016—Abbott introduced Alinity, its harmonized family of next-generation systems across immunoassay, clinical chemistry, point-of-care, hematology, blood and plasma screening, and molecular diagnostics. Each Alinity platform will include a number of features to help institutions, clinicians, and laboratorians better navigate through the health care environment.

On-demand assay for heparin-induced thrombocytopenia, 10/16

October 2016—Instrumentation Laboratory introduced several innovations in hemostasis at the meeting, including the FDA 510(k)-cleared HemosIL HIT-Ab(PF4-H) assay for use on ACL Top Family Hemostasis Testing Systems. The fully automated, on-demand assay for heparin-induced thrombocytopenia detects antibodies associated with HIT on a hemostasis testing system.

CSF automated cell counter, 10/16

October 2016—Advanced Instruments launched its GloCyte Automated Cell Counter System. The company announced in July that it received 510(k) clearance from the Food and Drug Administration to market its GloCyte Automated Cell Counter System and GloCyte Low and High Level Controls.

Blood test predicts adverse cardiovascular events, 9/16

September 2016—Mayo Clinic has launched a new type of blood test that will be used to predict adverse cardiovascular events in patients with progressing coronary artery disease. The test measures blood concentrations of plasma ceramides, a class of lipids that are highly linked to cardiovascular disease processes. Researchers say this test is especially useful for patients with CAD when it does not improve with treatment or for young patients with premature CAD.

Autopsy saw, 9/16

September 2016—Mopec introduced its Autopsy Saw 5000, which weighs less than three pounds and oscillates at 13,200 cycles per minute. Placement of the motor in the head and handle of the unit provides a balanced weight, resulting in a more precise cut with less operator fatigue, according to a company statement.

Wistar Institute grants Horizon exclusive license , 9/16

September 2016—Horizon Discovery Group and the Wistar Institute announced that Horizon has taken an exclusive license to 153 of Wistar’s melanoma patient-derived xenograft models. Horizon’s distribution of the Wistar melanoma PDX collection will allow scientists worldwide to investigate the efficacy and safety of its drugs prior to trials in human populations.

FDA-cleared automated microscope, 9/16

September 2016—Immuno Concepts announced that its Image Navigator automated microscope received 510(k) clearance. Image Navigator is a software program that controls a high-quality LED fluorescent microscope with a motorized stage to simplify and organize indirect fluorescent antibody testing.

Urine collection tube, 9/16

September 2016—Sarstedt introduced its 3.2 mL Urine Monovette tube in a 13 mm × 75 mm configuration for smaller volume or dimensional requirements. The Urine Monovette system enables hygienic urine collection and testing without needles, adapters or cups, or transfers.

MARKETPLACE

TRENDING